$VWFB
VWF Bancorp, Inc.

2023 Q3 Form 10-Q Financial Statement

#000155837023019230 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $2.081M
YoY Change 103.76%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $996.3K
YoY Change 1299.06%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$562.5K
YoY Change -410.37%
Income Tax -$123.7K
% Of Pretax Income
Net Earnings -$438.9K
YoY Change -383.54%
Net Earnings / Revenue -21.09%
Basic Earnings Per Share -$0.25
Diluted Earnings Per Share -$0.25
COMMON SHARES
Basic Shares Outstanding 1.777M
Diluted Shares Outstanding 1.777M

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $11.03M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.509M
YoY Change 11.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $214.8M
YoY Change 47.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $177.3M
YoY Change 65.93%
SHAREHOLDERS EQUITY
Retained Earnings $24.42M
YoY Change -4.65%
Common Stock $19.23K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $37.52M
YoY Change
Total Liabilities & Shareholders Equity $214.8M
YoY Change 47.3%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income -$438.9K
YoY Change -383.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$242.7K
YoY Change -121.5%
INVESTING ACTIVITIES
Capital Expenditures $116.7K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$43.41M
YoY Change 151.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 49.16M
YoY Change -1655.38%
NET CHANGE
Cash From Operating Activities -242.7K
Cash From Investing Activities -43.41M
Cash From Financing Activities 49.16M
Net Change In Cash 5.511M
YoY Change -128.6%
FREE CASH FLOW
Cash From Operating Activities -$242.7K
Capital Expenditures $116.7K
Free Cash Flow -$359.3K
YoY Change -131.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1776782
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1519110
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001913838
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1776782
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1519110
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2023Q3 vwfb Banking Regulation Tier1 Leverage Capital Ratio Grace Period
BankingRegulationTier1LeverageCapitalRatioGracePeriod
P6M
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
000-56459
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
VWF Bancorp, Inc.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-1256373
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
976 South Shannon Street
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Van Wert
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45891
CY2023Q3 dei City Area Code
CityAreaCode
419
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
238-9662
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1922924
CY2023Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
11026868
CY2023Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
5515728
CY2023Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
101527478
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
70585194
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
439239
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
263422
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
92264825
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
81208395
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1509190
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1409347
CY2023Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
702800
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
396800
CY2023Q3 us-gaap Federal Reserve Bank Stock
FederalReserveBankStock
536000
CY2023Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5253525
CY2023Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
5223496
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
604034
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
498807
CY2023Q3 us-gaap Other Assets
OtherAssets
1393711
CY2023Q2 us-gaap Other Assets
OtherAssets
1131536
CY2023Q3 us-gaap Assets
Assets
214818431
CY2023Q2 us-gaap Assets
Assets
165969303
CY2023Q3 us-gaap Demand Deposit Accounts
DemandDepositAccounts
26500024
CY2023Q2 us-gaap Demand Deposit Accounts
DemandDepositAccounts
26551336
CY2023Q3 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
38123901
CY2023Q2 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
42019749
CY2023Q3 us-gaap Time Deposits
TimeDeposits
74886452
CY2023Q2 us-gaap Time Deposits
TimeDeposits
51420496
CY2023Q3 us-gaap Deposits
Deposits
139510377
CY2023Q2 us-gaap Deposits
Deposits
119991581
CY2023Q3 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
13000000
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
6200000
CY2023Q3 vwfb Advances From Federal Reserve Bank
AdvancesFromFederalReserveBank
23000000
CY2023Q3 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
471736
CY2023Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
628795
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1312367
CY2023Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
650927
CY2023Q3 us-gaap Liabilities
Liabilities
177294480
CY2023Q2 us-gaap Liabilities
Liabilities
127471303
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1922924
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
19229
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
19229
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17875071
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17875071
CY2023Q3 vwfb Employee Stock Ownership Plan Shares Acquired
EmployeeStockOwnershipPlanSharesAcquired
-1461422
CY2023Q2 vwfb Employee Stock Ownership Plan Shares Acquired
EmployeeStockOwnershipPlanSharesAcquired
-1461422
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
24424456
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
24916481
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3333383
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2851359
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
37523951
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
38498000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
214818431
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
165969303
CY2023Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
889674
CY2022Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
687077
CY2023Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
1045771
CY2022Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
194217
CY2023Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
145300
CY2022Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
139877
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
2080745
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1021171
CY2023Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
703333
CY2022Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
71213
CY2023Q3 vwfb Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvances
292981
CY2023Q3 us-gaap Interest Expense
InterestExpense
996314
CY2022Q3 us-gaap Interest Expense
InterestExpense
71213
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1084431
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
949958
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
129022
CY2023Q3 vwfb Provision For Credit Losses Off Balance Sheet Credit Exposure
ProvisionForCreditLossesOffBalanceSheetCreditExposure
-357
CY2023Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
128665
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
955766
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
949958
CY2023Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
30029
CY2022Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
27426
CY2023Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
2866
CY2023Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
11437
CY2022Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
26750
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
44332
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
54176
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
714781
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
385518
CY2023Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
45700
CY2022Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
35000
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
136410
CY2022Q3 us-gaap Occupancy Net
OccupancyNet
50582
CY2023Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
84269
CY2022Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
62332
CY2023Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
41195
CY2022Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
38825
CY2023Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
19038
CY2022Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
9900
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
195946
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
155696
CY2023Q3 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-1951
CY2023Q3 vwfb Gain Loss On Sale Of Foreclosed Property
GainLossOnSaleOfForeclosedProperty
-2436
CY2023Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
320917
CY2022Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
85034
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
1562643
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
822887
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-562545
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
181247
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-123686
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26470
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-438859
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
154777
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1776782
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1519110
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-438859
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
154777
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
-610158
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
-1094445
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-128134
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-229834
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-482024
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-864611
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-920883
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-709834
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23367106
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16326487
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
154777
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-864611
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
38983759
CY2022Q3 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-141822
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1011257
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49161737
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3160746
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5511140
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19267507
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5515728
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36711842
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
38498000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-438859
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-482024
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
37523951
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-438859
CY2022Q3 us-gaap Profit Loss
ProfitLoss
154777
CY2023Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
19708
CY2022Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
15187
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-78192
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18844
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
123066
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11643
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
129022
CY2023Q3 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-1951
CY2023Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-2436
CY2023Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
2866
CY2023Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
30029
CY2022Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
27426
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
28844
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
55228
CY2023Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
105227
CY2022Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
101582
CY2023Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-107489
CY2022Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1001778
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-242657
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1128449
CY2022Q3 us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
490000
CY2023Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
36971788
CY2022Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
17251471
CY2023Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2989042
CY2023Q3 vwfb Proceeds From Maturities Prepayment And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentAndCallsOfAvailableForSaleSecurities
2506545
CY2022Q3 vwfb Proceeds From Maturities Prepayment And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentAndCallsOfAvailableForSaleSecurities
570021
CY2023Q3 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
27303
CY2023Q3 us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
-11268357
CY2022Q3 us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
-1387960
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
116685
CY2023Q3 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
505900
CY2023Q3 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
199900
CY2022Q3 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
344200
CY2023Q3 us-gaap Payments To Acquire Federal Reserve Stock
PaymentsToAcquireFederalReserveStock
268000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43407940
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17235210
CY2023Q3 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
19518796
CY2022Q3 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-4030181
CY2023Q3 vwfb Proceeds From Advance From Federal Home Loan Bank
ProceedsFromAdvanceFromFederalHomeLoanBank
13000000
CY2023Q3 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
6200000
CY2023Q3 vwfb Proceeds From Federal Reserve Bank Borrowings
ProceedsFromFederalReserveBankBorrowings
23000000
CY2023Q3 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-157059
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11026868
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17444335
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
715278
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
71888
CY2022Q3 us-gaap Stock Issued1
StockIssued1
15315230
CY2023Q3 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
29739
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Material estimates that are particularly susceptible to significant change relate to the determination of the allowance for credit losses, valuation of real estate acquired in connection with foreclosures or in satisfaction of loans, valuation of deferred tax assets and fair values of financial instruments.</p>
CY2023Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;"><span style="white-space:pre-wrap;">Certain reclassifications have been made to the September 30, 2022 consolidated financial statements to confirm to the September 30, 2023 consolidated financial statement presentation. These reclassifications had no effect on net earnings. </span></p>
CY2022Q3 us-gaap Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss
DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss
0
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
43965
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-438859
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
154777
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1922924
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1651206
CY2023Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
146142
CY2022Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
132096
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1776782
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1519110
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
105829284
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
3706272
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4345771
CY2023Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
101527478
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
74276842
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14624
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3706272
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
70585194
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
16992936
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
16943760
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
6421310
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5938122
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
3446438
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
2847194
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
1690659
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
1290092
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
28551343
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
27019168
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
77277941
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
74508310
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
105829284
CY2023Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
101527478
CY2022Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2023Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2989000
CY2023Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
2000
CY2023Q3 vwfb Investments In Debt Securities Reported Less Than Historical Cost Fair Value
InvestmentsInDebtSecuritiesReportedLessThanHistoricalCostFairValue
88976028
CY2023Q2 vwfb Investments In Debt Securities Reported Less Than Historical Cost Fair Value
InvestmentsInDebtSecuritiesReportedLessThanHistoricalCostFairValue
61878925
CY2023Q3 vwfb Investments In Debt Securities Reported Less Than Historical Cost Percentage
InvestmentsInDebtSecuritiesReportedLessThanHistoricalCostPercentage
0.88
CY2023 vwfb Investments In Debt Securities Reported Less Than Historical Cost Percentage
InvestmentsInDebtSecuritiesReportedLessThanHistoricalCostPercentage
0.88
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
63860134
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
520309
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
25115894
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3825462
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
88976028
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
4345771
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
41605352
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
688090
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
20273573
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3018182
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
61878925
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Fee And Loan In Process
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossFeeAndLoanInProcess
95762392
CY2023Q2 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
89722491
CY2023Q3 us-gaap Financing Receivable Loan In Process
FinancingReceivableLoanInProcess
3009490
CY2023Q2 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
8202918
CY2023Q3 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
-48838
CY2023Q2 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
-47756
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Current
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestCurrent
439239
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
263422
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
92264825
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
81208395
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
263422
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
129022
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
439239
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
222884
CY2023Q3 vwfb Financing Receivable Excluding Accrued Interest Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
439239
CY2023Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
414058
CY2023Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
92338844
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
7
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
263422
CY2023Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
304096
CY2023Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
89418395
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
95762392
CY2023Q2 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
89722491
CY2023Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
304096
CY2023Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
7
CY2023 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
309727
CY2023 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
11342
CY2023Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
414058
CY2023Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
414058
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
304096
CY2022Q3 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
0
CY2023Q3 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
0
CY2022Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2022Q3 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2023Q3 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
1
CY2023Q3 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.1743
CY2023Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.2269
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2023Q3 us-gaap Contractual Obligation
ContractualObligation
11521675
CY2023Q2 us-gaap Contractual Obligation
ContractualObligation
11022000

Files In Submission

Name View Source Status
0001558370-23-019230-index-headers.html Edgar Link pending
0001558370-23-019230-index.html Edgar Link pending
0001558370-23-019230.txt Edgar Link pending
0001558370-23-019230-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vwfb-20230930.xsd Edgar Link pending
vwfb-20230930x10q.htm Edgar Link pending
vwfb-20230930xex31d1.htm Edgar Link pending
vwfb-20230930xex31d2.htm Edgar Link pending
vwfb-20230930xex32.htm Edgar Link pending
vwfb-20230930_cal.xml Edgar Link unprocessable
vwfb-20230930_def.xml Edgar Link unprocessable
vwfb-20230930_lab.xml Edgar Link unprocessable
vwfb-20230930_pre.xml Edgar Link unprocessable
vwfb-20230930x10q_htm.xml Edgar Link completed